Hongbin Liu

657 total citations
22 papers, 483 citations indexed

About

Hongbin Liu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Hongbin Liu has authored 22 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Hongbin Liu's work include Coronary Interventions and Diagnostics (4 papers), Acute Myocardial Infarction Research (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Hongbin Liu is often cited by papers focused on Coronary Interventions and Diagnostics (4 papers), Acute Myocardial Infarction Research (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Hongbin Liu collaborates with scholars based in China, Hong Kong and United States. Hongbin Liu's co-authors include John R. Yates, Dayin Lin, Yang Bai, Jiaye Chen, Jun Xu, Fachao Zhi, Xiaofang Wang, Shengbo Chen, Hongmei Jing and Carolyn Buchwald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cell Death and Disease.

In The Last Decade

Hongbin Liu

22 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongbin Liu China 10 250 103 61 60 54 22 483
Zhuozhong Wang China 10 421 1.7× 88 0.9× 44 0.7× 33 0.6× 25 0.5× 25 618
Karim Chahed Tunisia 21 416 1.7× 81 0.8× 74 1.2× 107 1.8× 43 0.8× 50 883
Christin Stegemann Germany 13 607 2.4× 146 1.4× 108 1.8× 81 1.4× 103 1.9× 16 987
Jie Mao China 14 311 1.2× 33 0.3× 21 0.3× 100 1.7× 10 0.2× 40 565
Jungmin Lee South Korea 13 215 0.9× 14 0.1× 48 0.8× 39 0.7× 12 0.2× 33 580
Shannon Sweeney United States 12 275 1.1× 37 0.4× 20 0.3× 69 1.1× 7 0.1× 22 517
David Burnett United Kingdom 15 324 1.3× 14 0.1× 85 1.4× 44 0.7× 37 0.7× 34 725
Ke-Hung Tsui Taiwan 16 275 1.1× 63 0.6× 108 1.8× 47 0.8× 5 0.1× 39 631
James P. Luyendyk United States 10 128 0.5× 19 0.2× 26 0.4× 53 0.9× 17 0.3× 13 351
Axel Mündlein Austria 10 173 0.7× 12 0.1× 53 0.9× 191 3.2× 24 0.4× 14 617

Countries citing papers authored by Hongbin Liu

Since Specialization
Citations

This map shows the geographic impact of Hongbin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbin Liu more than expected).

Fields of papers citing papers by Hongbin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbin Liu. The network helps show where Hongbin Liu may publish in the future.

Co-authorship network of co-authors of Hongbin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongbin Liu. A scholar is included among the top collaborators of Hongbin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbin Liu. Hongbin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Jiuchang, Hongbin Liu, Weiming Li, et al.. (2024). LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization. Proceedings of the National Academy of Sciences. 121(35). e2405845121–e2405845121. 9 indexed citations
2.
Sun, Min, Qiaoning Yang, Wantong Zhang, et al.. (2024). Pharmacokinetics, safety, and efficacy of Fuqi Guben Gao in the treatment of kidney-yang deficiency syndrome: a randomized, double-blind phase I trial. Frontiers in Pharmacology. 15. 1351871–1351871. 1 indexed citations
3.
Xu, Juan, Xiaoqing Zhu, Xu Cui, et al.. (2024). The relationship between triglyceride-glucose index and prospective key clinical outcomes in patients hospitalised for coronary artery disease. Cardiovascular Diabetology. 23(1). 40–40. 9 indexed citations
4.
Zhao, Jia, Hongbin Liu, Zhixian Hong, et al.. (2023). Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC. Molecular Medicine. 29(1). 84–84. 18 indexed citations
5.
Zhou, Wenli, Yongyi Bai, Jianqiao Chen, et al.. (2022). Revealing the Critical Regulators of Modulated Smooth Muscle Cells in Atherosclerosis in Mice. Frontiers in Genetics. 13. 900358–900358. 7 indexed citations
6.
Qin, Qin, Guang Xu, Xiaoyan Zhan, et al.. (2021). Brevilin A inhibits NLRP3 inflammasome activation in vivo and in vitro by acting on the upstream of NLRP3-induced ASC oligomerization. Molecular Immunology. 135. 116–126. 20 indexed citations
7.
Xu, Jun, Xiaofang Wang, Jiaye Chen, et al.. (2020). Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice. Theranostics. 10(26). 12204–12222. 76 indexed citations
8.
Xu, Weihao, et al.. (2020). Frailty as a predictor of all-cause mortality and readmission in older patients with acute coronary syndrome. Wiener klinische Wochenschrift. 132(11-12). 301–309. 9 indexed citations
9.
Shi, Wei, Guang Xu, Xiaoyan Zhan, et al.. (2020). Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases. Cell Death and Disease. 11(4). 252–252. 48 indexed citations
10.
Wang, Wen‐An, Peng Dong, An Zhang, et al.. (2020). Artificial intelligence: A new budding star in gastric cancer. 1(4). 60–70. 1 indexed citations
11.
Gu, Xiaolong, Hongbin Liu, Chao Li, et al.. (2019). Selection and characterization of a precocious line of Eimeria media. Parasitology Research. 118(10). 3033–3041. 8 indexed citations
12.
Wang, Xi, et al.. (2018). The efficacy of antiplatelet therapies as evaluated by thrombo-elastography in retired Chinese officers. Cardiovascular journal of South Africa. 29(6). 357–361. 1 indexed citations
13.
Bian, Suyan, et al.. (2018). [Mesenchymal Stem Cells Stimulated by Growth Factors Release Exosomes with Potent Proangiogenic Activity].. PubMed. 26(5). 1538–1542. 1 indexed citations
14.
Li, Shan, Hongbin Liu, & Jianfeng Liu. (2016). Predictive performance of adding platelet reactivity on top of CRUSADE score for 1-year bleeding risk in patients with acute coronary syndrome. Journal of Thrombosis and Thrombolysis. 42(3). 360–368. 9 indexed citations
15.
16.
Wang, Yang, Changhua Xu, Ping Wang, et al.. (2013). Pharmacokinetic comparisons of different combinations of Shaoyao-Gancao-Decoction in rats: Simultaneous determination of ten active constituents by HPLC–MS/MS. Journal of Chromatography B. 932. 76–87. 52 indexed citations
17.
Jing, Hongmei, et al.. (2013). Diversity and Spatial Distribution of Hydrazine Oxidoreductase (hzo) Gene in the Oxygen Minimum Zone Off Costa Rica. PLoS ONE. 8(10). e78275–e78275. 33 indexed citations
18.
Chen, Yundai, et al.. (2011). A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting. Scandinavian Cardiovascular Journal. 45(2). 98–104. 7 indexed citations
19.
Chen, Yundai, Xinchun Yang, Lefeng Wang, et al.. (2011). Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Heart and Vessels. 27(3). 243–249. 26 indexed citations
20.
Long, Hongan, Hongbin Liu, Weiwei Liu, et al.. (2008). Two New Ciliates from Hong Kong Coastal Water: Orthodonella sinica n. sp. and Apokeronopsis wrighti n. sp. (Protozoa: Ciliophora). Journal of Eukaryotic Microbiology. 55(4). 321–330. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuozhong Wang Breakdown of academic impact, for papers by Karim Chahed Breakdown of academic impact, for papers by Christin Stegemann Breakdown of academic impact, for papers by Jie Mao Breakdown of academic impact, for papers by Jungmin Lee Breakdown of academic impact, for papers by Shannon Sweeney Breakdown of academic impact, for papers by David Burnett Breakdown of academic impact, for papers by Ke-Hung Tsui Breakdown of academic impact, for papers by James P. Luyendyk Breakdown of academic impact, for papers by Axel Mündlein
Rankless by CCL
2026